8-K - CG Oncology, Inc. - 5.02 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193125-26-152044
Filing Date: 2026-04-13
Accepted: 2026-04-13 08:30:08
Documents: 10
Period of Report: 2026-04-13
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
CG Oncology, Inc. (Filer) CIK : 0001991792 (see all company filings) EIN. : 371611499 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41925 | Film No.: 26856536 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | 8-K | ck0001991792-20260413.htm iXBRL | 8-K
2 | EX-10.1 | ck0001991792-ex10_1.htm | EX-10.1
3 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ck0001991792-20260413.xsd | EX-101.SCH
13 | EXTRACTED XBRL INSTANCE DOCUMENT | ck0001991792-20260413_htm.xml | XML